NCT00385047View on ClinicalTrials.gov

A Study to Determine Whether 2 Investigational Malaria Vaccines Are Safe, Protective Against Malaria in Adults

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

September 30, 2007

Conditions
Malaria
Interventions
BIOLOGICAL

Group A FMP2.1/AS01B

BIOLOGICAL

Group B FMP2.1/AS02A

Trial Locations (1)

20910

Clinical Trials Center, Walter Reed Army Institute of Research, Silver Spring

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

The PATH Malaria Vaccine Initiative (MVI)

OTHER

collaborator

GlaxoSmithKline

INDUSTRY

collaborator

United States Agency for International Development (USAID)

FED

lead

U.S. Army Medical Research and Development Command

FED